Substance Abuse and Mental Health Services Administration – Federal Register Recent Federal Regulation Documents

Results 401 - 450 of 1,520
HHS Approval of Entities That Certify Medical Review Officers
Document Number: 2018-17184
Type: Notice
Date: 2018-08-10
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice publishes a list of the Department of Health and Human Services (HHS) approved Medical Review Officers certification entities. The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), applicable on October 1, 2017, addresses the role and qualifications of Medical Review Officers (MROs) and HHS approval of entities that certify MROs.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-17127
Type: Notice
Date: 2018-08-10
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-17126
Type: Notice
Date: 2018-08-10
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-16440
Type: Notice
Date: 2018-08-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-16046
Type: Notice
Date: 2018-07-27
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-16045
Type: Notice
Date: 2018-07-27
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2018-15825
Type: Notice
Date: 2018-07-25
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment: Notice of Meeting
Document Number: 2018-15824
Type: Notice
Date: 2018-07-25
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2018-15677
Type: Notice
Date: 2018-07-23
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Meeting of the Substance Abuse and Mental Health Services Administration's (SAMHSA) National Advisory Council (SAMHSA NAC)
Document Number: 2018-15246
Type: Notice
Date: 2018-07-20
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice is hereby given of the meeting on August 2, 2018, of the Substance Abuse and Mental Health Services Administration's (SAMHSA) National Advisory Council (SAMHSA NAC).
Advisory Committee for Women's Services (ACWS); Notice of Meeting
Document Number: 2018-15227
Type: Notice
Date: 2018-07-17
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Mental Health Services; Notice of Meeting
Document Number: 2018-14381
Type: Notice
Date: 2018-07-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Statement of Organization, Functions, and Delegations of Authority
Document Number: 2018-14165
Type: Notice
Date: 2018-07-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-14143
Type: Notice
Date: 2018-07-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Notice of Meetings
Document Number: 2018-13878
Type: Notice
Date: 2018-06-28
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice is hereby given of the meetings on July 22-23, 2018, of the Substance Abuse and Mental Health Services Administration's (SAMHSA) Tribal Technical Advisory Committee (TTAC); on July 23 and July 25, 2018, of the Centers for Disease Control and Prevention (CDC)/ Agency for Toxic Substances and Disease Registry (ATSDR) Tribal Advisory Committee (TAC); and on July 24, 2018, of the Joint Tribal Advisory Committee (JTAC).
Notice of Meeting
Document Number: 2018-13116
Type: Notice
Date: 2018-06-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2018-12897
Type: Notice
Date: 2018-06-15
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2018-12865
Type: Notice
Date: 2018-06-15
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2018-12864
Type: Notice
Date: 2018-06-15
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment: Notice of Meeting
Document Number: 2018-12570
Type: Notice
Date: 2018-06-12
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-11809
Type: Notice
Date: 2018-06-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Agency Information Collection Activities: Submission for Office of Management and Budget (OMB) Review; Comment Request
Document Number: 2018-11536
Type: Notice
Date: 2018-05-30
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-10717
Type: Notice
Date: 2018-05-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-10716
Type: Notice
Date: 2018-05-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-09423
Type: Notice
Date: 2018-05-04
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-09178
Type: Notice
Date: 2018-05-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-09146
Type: Notice
Date: 2018-05-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting Center for Mental Health Services
Document Number: 2018-07693
Type: Notice
Date: 2018-04-13
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-07439
Type: Notice
Date: 2018-04-13
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2018-07493
Type: Notice
Date: 2018-04-11
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)-Correction
Document Number: 2018-07479
Type: Notice
Date: 2018-04-11
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This is a correction to the meeting announcement of the Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee published on the Federal Register, Vol. 83, No. 66/Thursday, April 5, 2018/Notices. FR Doc. 2018-06913. The notice of the meeting should have included the following statement: Members of the public can attend the meeting via telephone or webcast only, and not in person. The Secretary of Health and Human Services (Secretary), in accordance with section 6031 of the 21st Century Cures Act, announces a meeting of the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC). The meeting is open to the public and will include information on federal efforts related to serious mental illness (SMI) and serious emotional disturbance (SED), including data evaluation, and recommendations for action. Committee members will also discuss ISMICC member relationship to implementation workgroups, establishing the prevalence of SMI and SED, communication with non-federal organizations to engage non-federal support for ISMICC, and future meetings. Committee Name: Interdepartmental Serious Mental Illness Coordinating Committee.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-07438
Type: Notice
Date: 2018-04-11
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2018-07250
Type: Notice
Date: 2018-04-10
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2018-07021
Type: Notice
Date: 2018-04-06
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
Document Number: 2018-06913
Type: Notice
Date: 2018-04-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Secretary of Health and Human Services (Secretary), in accordance with section 6031 of the 21st Century Cures Act, announces a meeting of the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC). The meeting is open to the public and will include information on federal efforts related to serious mental illness (SMI) and serious emotional disturbance (SED), including data evaluation, and recommendations for action. Committee members will also discuss ISMICC member relationship to implementation workgroups, establishing the prevalence of SMI and SED, communication with non-federal organizations to engage non-federal support for ISMICC, and future meetings. Committee Name: Interdepartmental Serious Mental Illness Coordinating Committee.
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-06652
Type: Notice
Date: 2018-04-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-06184
Type: Notice
Date: 2018-03-28
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2018-04975
Type: Notice
Date: 2018-03-13
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-04444
Type: Notice
Date: 2018-03-06
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Center for Substance Abuse Prevention; Notice of Meeting
Document Number: 2018-03897
Type: Notice
Date: 2018-02-27
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting
Document Number: 2018-02173
Type: Notice
Date: 2018-02-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Meeting
Document Number: 2018-02172
Type: Notice
Date: 2018-02-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2018-02107
Type: Notice
Date: 2018-02-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Advisory Committee for Women's Services (ACWS); Notice of Meeting
Document Number: 2018-02010
Type: Notice
Date: 2018-02-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2018-01931
Type: Notice
Date: 2018-02-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Center for Substance Abuse Prevention; Notice of Meeting
Document Number: 2018-00369
Type: Notice
Date: 2018-01-11
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Confidentiality of Substance Use Disorder Patient Records
Document Number: 2018-00150
Type: Notice
Date: 2018-01-09
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) announces that it will hold a public listening session on Wednesday, January 31, 2018, to solicit information concerning the Confidentiality of Substance Use Disorder Patient Records regulations as required by Section 11002 of the 21st Century Cures Act. The listening session will provide an opportunity for the public to provide input to SAMHSA concerning the effect of part 2 on ``patient care, health outcomes, and patient privacy'' as well as potential regulatory changes and future subregulatory guidance.
Center for Mental Health Services: Notice of Meeting
Document Number: 2018-00149
Type: Notice
Date: 2018-01-09
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies
Document Number: 2017-28249
Type: Notice
Date: 2018-01-02
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at https:// www.samhsa.gov/workplace.
Center for Substance Abuse Treatment; Notice of Meeting
Document Number: 2017-28107
Type: Notice
Date: 2017-12-29
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.